Estudios del laboratorio de diversos parámetros orientados a tratar de dilucidar la fisiopatología del síndrome de ovarios poliquísticos (SOP). Parte 2 / Laboratory studies of several parameters aimed to elucidate the pathophysiology of polycystic ovary syndrome. Second part

RESUMEN Diversos estudios bioquímicos adicionales a la evaluación de Testosterona total (TT), biodisponible (Tbio) y libre (TL) han sido realizados a los efectos que pudieran resultar de mayor utilidad para el diagnóstico de patologías concomitantes en el SOP, entre otros. En la hormona anti Mülleriana, cuando la concentración supera a los 3,0 ng/ml existen evidencias de que el 79% de las mismas pueden ser identificadas correctamente como SOP. El Antígeno Prostático Específico (PSA), marcador de singular importancia en pacientes con cáncer de Próstata, con técnicas ultrasensibles ha podido ser detectado en más del 50% en mujeres. En un grupo de pacientes con SOP, los niveles circulantes de PSA fueron significativamente mayores que en las mujeres sin SOP. El Kiss-1 aislado de la placenta y demostrado en otros tejidos, presenta niveles aumentados que correlacionan con la LH, TT, TL y resistencia a la insulina (RI) en adolescentes con SOP versus adolescentes sin SOP, sugiriendo que el Kiss-1 podría estar involucrado en el desarrollo del SOP en estas pacientes. Algunas pacientes con SOP están asociadas a patologías relevantes, de las cuales han sido comunicadas el aumento del BMI, mayor grado de dislipemia, adiposidad central, RI y Síndrome Metabólico (SMe). En las pacientes con un fenotipo clásico (hiperandrogenismo, alteración del ciclo menstrual y ovarios poliquísticos), estas patologías son de mayor frecuencia y severidad que en los otros fenotipos, particularmente aquellos sin hiperandrogenismo. Otras determinaciones como TNFα, interleuquinas, test de tolerancia a la glucosa, ApoB, partículas pequeñas de LDL e Inhibidor del Activador del Plasminógeno-1 han sido comunicados que podrían ser de utilidad para tener mayor sensibilidad en la definición de patología concomitantes en el SOP. Actualmente se ha comenzado a evaluar otros marcadores como el Fetuin-A; Quemerina, Nesfatina-1, Neopterina y Endocannabinoides, cuyos resultados preliminares parecerían ser un aporte importante para evaluar SMe y RI en paciente con SOP y tratar de definir su prevalencia en los distintos fenotipos de esta patología.

ABSTRACT Several biochemical studies in addition to the evaluation of total Testosterone (TT), bioavailable (bioT) and free (FT) have been performed to the effects that could be of greater use for the diagnosis of concomitant pathologies in the PCOS, among others. The anti-Müllerian hormone whose concentration when exceeds 3.0 ng/ml, there is evidence that 79% of these patients can be correctly identified as PCOS. The Prostate-Specific Antigen (PSA), a marker of singular importance in patients with prostate cancer, with ultra-sensitive techniques, has been detected in more than 50% of women. In a group of patients with PCOS, circulating levels of PSA are significantly higher than in women without PCOS. The Kiss-1 isolated from the placenta and demonstrated in other tissues, has increased levels that correlate with LH, TT, TL and insulin resistance (IR) in adolescents with PCOS respect to adolescents without PCOS, suggesting that Kiss-1 could be involved in the development of the PCOS in these patients. In some patients with PCOS, they are associated with relevant pathologies, of which the increase in BMI, higher degree of dyslipidemia, central adiposity, IR and Metabolic Syndrome (MeS) have been reported. Those that show a classic phenotype (hyperandrogenism, alteration of the menstrual cycle and polycystic ovaries) these characteristics are of greater frequency and severity than in the other phenotypes, particularly those without hyperandrogenism. Other determinations such as TNFα, interleukins, glucose tolerance test, ApoB, small particles of LDL and Plasminogen Activator Inhibitor-1 have been reported that could be useful to have greater sensitivity in the definition of concomitant pathology in the PCOS. Currently, other markers such as Fetuin-A, Chemerin, Nesfatin-1 Neopterin and Endocannabinoids have been evaluated. The preliminary results suggest to be an important contribution to define MeS and IR in patient with PCOS and to try to determine its prevalence in the different phenotypes of this pathology.

Estudios de laboratorio de diversos parámetros orientados a tratar de dilucidar la fisiopatología del síndrome de ovarios poliquísticos. Parte 1 / Laboratory studies of various parameters aimed at trying to elucidate the pathophysiology of polycystic ovary syndrome. Part 1

Esta revisión fue realizada con el fin de evaluar nuestros resultados de laboratorio así como aquellos de la literatura que constituyen, a nuestro entender, aportes significativos en el síndrome de ovarios poliquísticos (SOP). Nuestro especial énfasis será presentar las limitaciones de las metodologías empleadas por nuestro grupo, comparativamente a las reportadas por otros investigadores. La determinación de andrógenos, en particular de Testosterona (TT), es quizá la de mayor complejidad dado que los resultados con los diferentes inmunoensayos empleados en nuestro medio producen resultados muy variables por los diferentes métodos y aún entre laboratorios que usan la misma metodología. La técnica de referencia es la cromatografía líquida en tándem con espectrometría de masa (LC-MSMS), de difícil aplicación en laboratorios de análisis clínicos debido a su alto costo y la imposibilidad de resolver numerosas muestras. En estudios previos demostramos que de los métodos habitualmente usados para evaluar la TT circulante, solo en 2 inmunoensayos los resultados obtenidos fueron satisfactoriamente validados indirectamente según el criterio del Consenso de los Centros para el Control y Prevención de Enfermedades (CDC, USA) contra LC-MSMS, los cuales fueron comparables a dicha metodología con niveles superiores a 0,5 ng/ml. El SOP puede presentar factores de riesgo aumentados para la enfermedad cardiovascular y la diabetes II. Estos factores no están debidamente categorizados en función de los distintos fenotipos del SOP. Se evaluarán los principales analitos empleados con este objetivo y los nuevos que aporten elementos de mayor especificidad en este sentido

This review was performed in order to evaluate our laboratory results as well as those of the literature that constitute, in our opinion, significant contributions in these pathophysiologies. Our special emphasis will be on presenting the limitations of the methodologies used by our group, compared to those reported by other researchers. The determination of androgens, in particular Testosterone (TT), is perhaps the most complex since the results with the different immunoassays used in our environment produce very variable results by the different methods and even between laboratories that use the same methodology. The reference technique is LC-MSMS, difficult to apply in clinical analysis laboratories because of its high cost and the inability to solve numerous samples. In previous studies, we demonstrated that, in comparison to LC-MSMS with the usual methods for evaluating circulating TT, the results obtained in only 2 immunoassays were satisfactorily validated indirectly according to the criteria of CDC against LC-MSMS, which were comparable to that methodology with levels higher than 0.5 ng/ml. PCOS may have increased risk factors for cardiovascular disease and diabetes II. These factors are not properly categorized according to the different phenotypes of PCOS. The main analytes used for this purpose will be evaluated and new ones that contribute elements of greater specificity in this sense

A Comparison of Serum Testosterone (T) Measurements by Various Methods, Employing Current Validated Techniques or Otherwise, and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Multicentric Study / Comparación de los resultados de testosterona (T) por cromatografía líquida en tandem con espectrometría de masa (LC-MS/MS) y por kits comerciales convalidados o no por LC-MS/MS

Objective: To compare normal and hirsute women Testosterone (T) measurements performed at different laboratories by the same or different methods, and the gold standard method LC-MS/MS (Quest Diagnostics, USA). Design: Prospective study. Setting: Hormone Determination Laboratory, Hospital Italiano, La Plata, and each participating laboratory's private practice. Patient(s): Blood samples were obtained from 23 individuals sorted into two groups, namely, normal women, n: 11(NW) and hirsute women, n: 12 (HW). Interventions(s): None. Main Outcome Measure(s): To evaluate whether serum T measurements obtained from each serum by the methods currently employed in our country, some of whose kits exhibit changes in previous presentations, some LC-MS/MS-validated and other non-validated ones are significantly different from those obtained by LC-MS/MS. Result(s): None of the 11 NW showed high T values by LC-MS/MS. Two out of the 12 hirsute patients showed normal T values (LC-MS/MS). Methods and number of participating labs -shown between brackets were: in NW, 1st generation Architect (1), 2nd generation Architect (1); Immulite (1) Cobas (4); Access (1); Centaur (2); Immunotech-RIA (1); and, in HW, 2nd generation Architect (3); Immulite (3); Cobas (4); Access (1); Centaur (2); Immunotech-RIA (1). No false positives resulted from the assays performed. No lab yielded false positive results in the NW group. No false positives were reported from the 10 hirsute women with increased T values by LC-MS/MS. False positives, though, resulted from two female hirsute patients with normal T values studied by four of the methods. Statistically, the serum T measurements obtained were significantly different by Centaur in NW and, in HW, by Immulite and Centaur as compared to LC-MS/MS. In the Bland-Altman plot, Centaur and Cobas showed over 5 % of measurements outside the limits of agreement in the HW group. Assessment by p-Spearman resulted in divergences with LC-MS/MS for all methods in NW, whereas in the HW group there were none. When estimating sampling bias for each laboratory taking LC-MS/MS as the reference method and adopting a ± 6.4 % mean bias acceptability criterion for each method compared to LC-MS/MS, two of the techniques reviewed, 2nd generation Architect and Cobas, met the validation requirement satisfactorily. However, one lab out of three using 2nd generation Architect failed to meet the validation requirement, while two out of four labs using Cobas also failed to meet the requirement. This demonstrates the great variability among methods, even when labs are employing the same technique. Conclusion: From the clinical point of view, the methods currently used in our local environment yielded no false positives or false negatives and therefore did not misdiagnose hyperandrogenism. Still, Immulite, Centaur, RIA and Access did present false positives in two of the T-normal hirsute women. The relation of serum T measurements obtained by each method to measurements obtained by LC-MS/MS reveals that the dispersion of the results was larger with values under 0.3 ng/ml, quite close to the detection limit of the various techniques.

Objetivos: Comparar los resultados de testosterona (T) obtenidos en diferentes laboratorios en mujeres normales (MN) e hirsutas (MH), empleando el mismo o diferentes métodos respecto a la técnica de cromatografía líquida en tándem con espectrometría de masa LC-MS/MS (gold standard) realizada en el laboratorio Quest (USA) Protocolo: Estudio prospectivo Estudio realizado en: Laboratorio de Determinaciones Hormonales; Hospital Italiano de La Plata y en los laboratorios privados de cada participante Pacientes: Se obtuvieron muestras de sangre periférica en 23 mujeres agrupadas en 2 grupos: controles normales (n:11) y en mujeres hirsutas (n: 12) Intervención: Ninguna. Principales resultados a evaluar: Evaluar si con los métodos habituales empleados en nuestro medio con los diferentes kits comerciales, de los cuales algunos han sido convalidados por técnica "gold standard" y otros no, presentan diferencias significativas con los obtenidos por LC-MS/MS Resultados: Los resultados obtenidos por LC-MS/MS mostraron que ninguna de las 11 MN tuvieron niveles aumentado de T y 2 MH tuvieron valores normales de T. Los métodos empleados y el número de laboratorios (entre paréntesis) que emplearon cada método fueron en MN Architect 1st generation (1) Architect 2nd generation (1); Immulite (1); Cobas (4); Access (1); Centauro (2); Immunotech-RIA (1). En las MH Architect 2nd generation (3); Immulite (3); Cobas (4); Access (1); Centauro (2); Immunotech-RIA (1). En el grupo de MN en ningún laboratorio (lab) se obtuvieron resultados falsos positivos. En el grupo de MH no se obtuvieron falsos negativos en las 10 hirsutas con valores aumentados de T por LC-MS/MS. En las 2 pacientes hirsutas con T normal en 4 métodos se obtuvieron falsos positivos Estadísticamente los resultados fueron significativamente diferentes, en las MN por Centauro y en las MH por Immulite y Centauro. En el análisis de Bland-Altman Centauro y Cobas en las MH presentaron más del 5 % de los resultados fuera del límite de acuerdo. Resultados por p-Speerman todos los métodos fueron diferentes a LC-MSMS en las MN y no se obtuvieron diferencias en el grupo de MH. Evaluando el bias de cada muestra en cada laboratorio respecto a LC-MS/MS y adoptando el criterio de aceptabilidad de ± 6,4 % mean bias de cada método respecto al de LC-MS/MS, 2 de las metodologías estudiadas, Architect 2da generación y Cobas pasaron satisfactoriamente el requisito de validación, sin embargo de los 3 laboratorios que emplearon 2da generación, 1 no pasó el criterio de validación y de los 4 que usaron Cobas, 2 tampoco lo pasaron. Esto demuestra la gran variabilidad de los métodos aun entre lab que emplean la misma técnica. Conclusiones: Desde el punto de vista clínico los métodos habitualmente empleados en nuestro medio, no sobrediagnosticaron o subdiagnosticaron hiperandrogenismo, por no presentar falsos positivos o negativos respectivamente. Sin embargo Immulite, Centauro, RIA y Access presentaron falsos positivos en las 2 hirsutas con T normal. En la relación de los resultados de cada muestra en cada método sobre el valor de LC-MS/MS referido a la concentración de T en ese suero por LC-MS/MS, la mayor dispersión de los resultados se observaron con valores menores de 0,3 ng/ml, muy cercano al límite de detección de las diferentes técnicas.

Quantification of Testosterone (T) by 8 Immunoassays and by Liquid Chromatography -Tandem Mass Spectrometry (LC-MSMS) in Normal and Hirsute Women: A Multicenter Study / Cuantificación de testosterona (T) por 8 inmunoensayos y por cromatografía líquida en tandem con espectrometría de masa (LC MS/MS): En mujeres normales e hirsutas. Estudio multicéntrico

Objective: To compare T results in normal and hirsute women, obtained by different laboratories employing the same or different methods, including an in-home RIA, and the gold standard method LC-MS/MS. In addition, T results were referred to a curve obtained by 6 different pools that had been prepared on the basis of LC-MS/MS results. Design: Prospective study Setting: Hormone Determination Laboratory, Hospital Italiano, La Plata, and private practice of each participant laboratory. Patient(s): Blood samples were obtained from 78 individuals sorted into 3 groups, namely, normal men (n:39), normal women (n:24) and hirsute women (n:15) Interventions(s): None Main Outcome Measure(s): To evaluate if the results obtained in each lab for each serum sample by the methods currently employed in our country are significantly different from those obtained by LC-MS/MS (Gold standard) Result(s) One out of the 24 NW showed high T values by LC - MS/MS. In each lab, except in 1 (Architect) T results of this serum sample were normal. Two out of the 15 hirsute patients showed normal T values (LC - MS/MS). Method and number of labs -shown between brackets- and percentages of normal T results (false negatives) are described for each method as follows: Chemiluminescence: Axsym - Abbott (Axn) - (3) 85, Architect - Abbott - (Arch); (2) 70; Immulite - Siemmens - (IMM); (2) 42; Electrochemiluminescence - Elecsys - Roche- ((EQL); (4) 52; Fluorescent enzymatic - Vidas - Bio-Merieux - (Vidas) (1) 69; Manual coated tube radioimmunoassay (RIA): RIA - Siemmens Coat-a-Count (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; and in-Home RIA (in-H) (1) 12. Statistically significant differences were obtained between different methods and against LC MS/MS. In-H method is the one that comes closest to 1 on the Weighted Deming regression and closest to zero on the SD intercept, (standard deviation of the constant in the straight line equation) indicating that the values match those obtained by LC - MS/MS. The values recorded by the various methods employed showed no significant modifications when plotted against a secondary standard curve. Conclusion(s) This indicates that the techniques in current use in our area underestimate hyperandrogenemia in these patients. Discrepancies are not due to the various calibration curves proposed in the corresponding commercial kits. The fact that the In-H technique affords finer results while employing a larger serum volume suggests that the disparities among the various commercial methods result from their limited sensitivity to the sample volumes they process.

El diagnóstico de hiperandrogenemia requiere la demostración de niveles aumentados de Testosterona Total (TT) en suero. Los inmuno ensayos comerciales dan resultados divergentes a niveles bajos de TT como los obtenidos en mujeres. Valoramos los niveles de TT en 24 mujeres normales (MN) y 15 hirsutas (MH) en 18 laboratorios por métodos comúnmente empleados en nuestro medio. Los métodos y número de laboratorio que emplearon cada método se muestra entre paréntesis así como los porcentajes de T normal (falsos negativos) obtenidos en cada método fueron: Quimioluminiscencia: Axsym - Abbott (Axn)- (3) (85), Architect - Abbott - (Arch); (2) 70; Immulite - Siemmens - (IMM); (2) 42; Electroquimioluminiscencia - Elecsys - Roche- ((EQL); (4) 52; Enzimático acoplado a fluorescencia Vidas - Bio-Merieux - (Vidas) (1) 69, Radioinmunoiensayo en tubo recubierto (RIA): RIA - Siemmens (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; y un método desarrollado en uno de los laboratorios (in-H) (1) 12. Comparativamente a LC MS/MS los niveles fueron en todas las muestras significativamente más bajos por Axn y en 18 de las 24 MN por DiaS. En 7 casos; 3 por RIA S, 2 por IMM y 1 por EQL y Arch los valores de TT fueron superiores al límite superior de sus respectivos métodos. En todos los casos se obtuvo una gran variación entre los mismos y con diferentes métodos. Trece de las 15 MH tuvieron niveles altos de TT por LC MS/MS. De las MH con TT aumentada de acuerdo a la determinación por LC MS/MS entre el 12 y el 85 % de las mismas por los distintos métodos fueron normales, indicando que en la mayoría de los métodos habitualmente utilizados en nuestro medio subvaloran la hipernadrogenemia en estas pacientes. Estas diferencias se hacen más notorias a niveles más bajos de TT (Se obtuvieron valores normales en el 71 % de los casos con valores de TT entre 0,47 y 0,74 ng/ml y en el 38 % de los casos, con niveles de TT mayor a 0,98 ng/ml). ...

Quantification of Testosterone (T) by 8 Immunoassays and by Liquid Chromatography -Tandem Mass Spectrometry (LC-MSMS) in Normal and Hirsute Women: A Multicenter Study / Cuantificación de testosterona (T) por 8 inmunoensayos y por cromatografía líquida en tandem con espectrometría de masa (LC MS/MS): En mujeres normales e hirsutas. Estudio multicéntrico

Objective: To compare T results in normal and hirsute women, obtained by different laboratories employing the same or different methods, including an in-home RIA, and the gold standard method LC-MS/MS. In addition, T results were referred to a curve obtained by 6 different pools that had been prepared on the basis of LC-MS/MS results. Design: Prospective study Setting: Hormone Determination Laboratory, Hospital Italiano, La Plata, and private practice of each participant laboratory. Patient(s): Blood samples were obtained from 78 individuals sorted into 3 groups, namely, normal men (n:39), normal women (n:24) and hirsute women (n:15) Interventions(s): None Main Outcome Measure(s): To evaluate if the results obtained in each lab for each serum sample by the methods currently employed in our country are significantly different from those obtained by LC-MS/MS (Gold standard) Result(s) One out of the 24 NW showed high T values by LC - MS/MS. In each lab, except in 1 (Architect) T results of this serum sample were normal. Two out of the 15 hirsute patients showed normal T values (LC - MS/MS). Method and number of labs -shown between brackets- and percentages of normal T results (false negatives) are described for each method as follows: Chemiluminescence: Axsym - Abbott (Axn) - (3) 85, Architect - Abbott - (Arch); (2) 70; Immulite - Siemmens - (IMM); (2) 42; Electrochemiluminescence - Elecsys - Roche- ((EQL); (4) 52; Fluorescent enzymatic - Vidas - Bio-Merieux - (Vidas) (1) 69; Manual coated tube radioimmunoassay (RIA): RIA - Siemmens Coat-a-Count (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; and in-Home RIA (in-H) (1) 12. Statistically significant differences were obtained between different methods and against LC MS/MS. In-H method is the one that comes closest to 1 on the Weighted Deming regression and closest to zero on the SD intercept, (standard deviation of the constant in the straight line equation) indicating that the values match those obtained by LC - MS/MS. The values recorded by the various methods employed showed no significant modifications when plotted against a secondary standard curve. Conclusion(s) This indicates that the techniques in current use in our area underestimate hyperandrogenemia in these patients. Discrepancies are not due to the various calibration curves proposed in the corresponding commercial kits. The fact that the In-H technique affords finer results while employing a larger serum volume suggests that the disparities among the various commercial methods result from their limited sensitivity to the sample volumes they process.(AU)

El diagnóstico de hiperandrogenemia requiere la demostración de niveles aumentados de Testosterona Total (TT) en suero. Los inmuno ensayos comerciales dan resultados divergentes a niveles bajos de TT como los obtenidos en mujeres. Valoramos los niveles de TT en 24 mujeres normales (MN) y 15 hirsutas (MH) en 18 laboratorios por métodos comúnmente empleados en nuestro medio. Los métodos y número de laboratorio que emplearon cada método se muestra entre paréntesis así como los porcentajes de T normal (falsos negativos) obtenidos en cada método fueron: Quimioluminiscencia: Axsym - Abbott (Axn)- (3) (85), Architect - Abbott - (Arch); (2) 70; Immulite - Siemmens - (IMM); (2) 42; Electroquimioluminiscencia - Elecsys - Roche- ((EQL); (4) 52; Enzimático acoplado a fluorescencia Vidas - Bio-Merieux - (Vidas) (1) 69, Radioinmunoiensayo en tubo recubierto (RIA): RIA - Siemmens (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; y un método desarrollado en uno de los laboratorios (in-H) (1) 12. Comparativamente a LC MS/MS los niveles fueron en todas las muestras significativamente más bajos por Axn y en 18 de las 24 MN por DiaS. En 7 casos; 3 por RIA S, 2 por IMM y 1 por EQL y Arch los valores de TT fueron superiores al límite superior de sus respectivos métodos. En todos los casos se obtuvo una gran variación entre los mismos y con diferentes métodos. Trece de las 15 MH tuvieron niveles altos de TT por LC MS/MS. De las MH con TT aumentada de acuerdo a la determinación por LC MS/MS entre el 12 y el 85 % de las mismas por los distintos métodos fueron normales, indicando que en la mayoría de los métodos habitualmente utilizados en nuestro medio subvaloran la hipernadrogenemia en estas pacientes. Estas diferencias se hacen más notorias a niveles más bajos de TT (Se obtuvieron valores normales en el 71 % de los casos con valores de TT entre 0,47 y 0,74 ng/ml y en el 38 % de los casos, con niveles de TT mayor a 0,98 ng/ml). ...(AU)

Quantification of Testosterone (t) by 8 Immunoassays and by Liquid Chromatography -Tandem mass Spectrometry (lc -msms) in Normal and Hirsute Women: A Multicenter Study / Cuantificación de testosterona (t) por 8 inmunoensayos y por cromatografía líquida en tandem con espectrometría de masa (Lc ms/ms): En mujeres normales e hirsutas. Estudio multicéntrico

Objective: To compare T results in normal and hirsute women, obtained by different laboratories employing the same or different methods, including an in-home RIA, and the gold standard method LC-MS/MS. In addition, T results were referred to a curve obtained by 6 different pools that had been prepared on the basis of LC-MS/MS results. Design: Prospective study Setting: Hormone Determination Laboratory, Hospital Italiano, La Plata, and private practice of each participant laboratory. Patient(s): Blood samples were obtained from 78 individuals sorted into 3 groups, namely, normal men (n:39), normal women (n:24) and hirsute women (n:15) Interventions(s): None Main Outcome Measure(s): To evaluate if the results obtained in each lab for each serum sample by the methods currently employed in our country are significantly different from those obtained by LC-MS/MS (Gold standard) Result(s) One out of the 24 NW showed high T values by LC - MS/MS. In each lab, except in 1 (Architect) T results of this serum sample were normal. Two out of the 15 hirsute patients showed normal T values (LC - MS/MS). Method and number of labs -shown between brackets- and percentages of normal T results (false negatives) are described for each method as follows: Chemiluminescence: Axsym - Abbott (Axn) - (3) 85, Architect - Abbott - (Arch); (2) 70; Immulite - Siemmens - (IMM); (2) 42; Electrochemiluminescence - Elecsys - Roche- ((EQL); (4) 52; Fluorescent enzymatic - Vidas - Bio-Merieux - (Vidas) (1) 69; Manual coated tube radioimmunoassay (RIA): RIA - Siemmens Coat-a-Count (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; and in-Home RIA (in-H) (1) 12. Statistically significant differences were obtained between different methods and against LC MS/MS. In-H method is the one that comes closest to 1 on the Weighted Deming regression and closest to zero on the SD intercept, (standard deviation of the constant in the straight line equation) indicating that the values match those obtained by LC - MS/MS. The values recorded by the various methods employed showed no significant modifications when plotted against a secondary standard curve. Conclusion(s) This indicates that the techniques in current use in our area underestimate hyperandrogenemia in these patients. Discrepancies are not due to the various calibration curves proposed in the corresponding commercial kits. The fact that the In-H technique affords finer results while employing a larger serum volume suggests that the disparities among the various commercial methods result from their limited sensitivity to the sample volumes they process. No financial conflicts of interest exist.

El diagnóstico de hiperandrogenemia requiere la demostración de niveles aumentados de Testosterona Total (TT) en suero. Los inmuno ensayos comerciales dan resultados divergentes a niveles bajos de TT como los obtenidos en mujeres. Valoramos los niveles de TT en 24 mujeres normales (MN) y 15 hirsutas (MH) en 18 laboratorios por métodos comúnmente empleados en nuestro medio, Quimioluminiscencia: Axsym - Abbott (Axn)- (3 ), Architect - Abbott - (Arch); (2); Immulite - Siemmens - (IMM); (2); Electroquimioluminiscencia - Elecsys - Roche- ((EQL); (4); Enzimático acoplado a fluorescencia Vidas - Bio-Merieux - (Vidas) (1), Radioinmunoiensayo en tubo recubierto (RIA): RIA - Siemmens (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; y un metodo desarrollado en uno de los laboratorios (in-H) (1).El número entreparéntesis indica elnúmero de laboratorios que emplearon la misma técnica,y comparamos los resultados por LC MS/MS. Comparativamente a LC MS/MS los niveles fueron en todas las muestras significativamente más bajos por AXS y en 18 de las 24 MN por DiaS. En 7 casos; 3 por RIA S, 2 por IMM y 1 por EQL y Arch los valores de TT fueron superiores al límite superior de sus respectivos métodos. En todos los casos se obtuvo una gran variación entre los mismos y con diferentes métodos. Trece de las 15 MH tuvieron niveles altos de TT por LC MS/MS. De las MH con TT aumentada de acuerdo a la determinación por LC MS/MS entre el 12 y el 85 % de las mismas por los distintos métodos fueron normales, indicando que en la mayoría de los métodos habitualmente utilizados en nuestro medio subvaloran la hipernadrogenemia en estas pacientes. Estas diferencias se hacen más notorias a niveles más bajos de TT (Se obtuvieron valores normales en el 71 % de los casos con valores de TT entre 0.47 y 0.74 ng/ml y en el 38 % de los casos, con niveles de TT mayor a 0.98 ng/ml). En 9 muestras se determinó la TT empleando una curva en el rango de 0.21 a 6.44 ng/ml preparada con de una mezcla de 78 sueros cuyos valores fueron obtenidos por LC MS/MS. No se obtuvo una modificación significativa de los valores indicando que la diferencia entre los distintos métodos no es debida a las diferentes curvas de calibración de los kit comerciales. En conclusión ninguno de los métodos mayormente empleados en nuestro medio son aceptables para la evaluación de niveles menores a 1.5 ng/ml.

Quantification of Testosterone (t) by 8 Immunoassays and by Liquid Chromatography -Tandem mass Spectrometry (lc -msms) in Normal and Hirsute Women: A Multicenter Study / Cuantificación de testosterona (t) por 8 inmunoensayos y por cromatografía líquida en tandem con espectrometría de masa (Lc ms/ms): En mujeres normales e hirsutas. Estudio multicéntrico

Objective: To compare T results in normal and hirsute women, obtained by different laboratories employing the same or different methods, including an in-home RIA, and the gold standard method LC-MS/MS. In addition, T results were referred to a curve obtained by 6 different pools that had been prepared on the basis of LC-MS/MS results. Design: Prospective study Setting: Hormone Determination Laboratory, Hospital Italiano, La Plata, and private practice of each participant laboratory. Patient(s): Blood samples were obtained from 78 individuals sorted into 3 groups, namely, normal men (n:39), normal women (n:24) and hirsute women (n:15) Interventions(s): None Main Outcome Measure(s): To evaluate if the results obtained in each lab for each serum sample by the methods currently employed in our country are significantly different from those obtained by LC-MS/MS (Gold standard) Result(s) One out of the 24 NW showed high T values by LC - MS/MS. In each lab, except in 1 (Architect) T results of this serum sample were normal. Two out of the 15 hirsute patients showed normal T values (LC - MS/MS). Method and number of labs -shown between brackets- and percentages of normal T results (false negatives) are described for each method as follows: Chemiluminescence: Axsym - Abbott (Axn) - (3) 85, Architect - Abbott - (Arch); (2) 70; Immulite - Siemmens - (IMM); (2) 42; Electrochemiluminescence - Elecsys - Roche- ((EQL); (4) 52; Fluorescent enzymatic - Vidas - Bio-Merieux - (Vidas) (1) 69; Manual coated tube radioimmunoassay (RIA): RIA - Siemmens Coat-a-Count (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; and in-Home RIA (in-H) (1) 12. Statistically significant differences were obtained between different methods and against LC MS/MS. In-H method is the one that comes closest to 1 on the Weighted Deming regression and closest to zero on the SD intercept, (standard deviation of the constant in the straight line equation) indicating that the values match those obtained by LC - MS/MS. The values recorded by the various methods employed showed no significant modifications when plotted against a secondary standard curve. Conclusion(s) This indicates that the techniques in current use in our area underestimate hyperandrogenemia in these patients. Discrepancies are not due to the various calibration curves proposed in the corresponding commercial kits. The fact that the In-H technique affords finer results while employing a larger serum volume suggests that the disparities among the various commercial methods result from their limited sensitivity to the sample volumes they process. No financial conflicts of interest exist.(AU)

El diagnóstico de hiperandrogenemia requiere la demostración de niveles aumentados de Testosterona Total (TT) en suero. Los inmuno ensayos comerciales dan resultados divergentes a niveles bajos de TT como los obtenidos en mujeres. Valoramos los niveles de TT en 24 mujeres normales (MN) y 15 hirsutas (MH) en 18 laboratorios por métodos comúnmente empleados en nuestro medio, Quimioluminiscencia: Axsym - Abbott (Axn)- (3 ), Architect - Abbott - (Arch); (2); Immulite - Siemmens - (IMM); (2); Electroquimioluminiscencia - Elecsys - Roche- ((EQL); (4); Enzimático acoplado a fluorescencia Vidas - Bio-Merieux - (Vidas) (1), Radioinmunoiensayo en tubo recubierto (RIA): RIA - Siemmens (RIA S); (3) 64; RIA - DSL Inc (RIA DSL); (1) 31; RIA - DIASource - (DiaS); (1) 31; y un metodo desarrollado en uno de los laboratorios (in-H) (1).El número entreparéntesis indica elnúmero de laboratorios que emplearon la misma técnica,y comparamos los resultados por LC MS/MS. Comparativamente a LC MS/MS los niveles fueron en todas las muestras significativamente más bajos por AXS y en 18 de las 24 MN por DiaS. En 7 casos; 3 por RIA S, 2 por IMM y 1 por EQL y Arch los valores de TT fueron superiores al límite superior de sus respectivos métodos. En todos los casos se obtuvo una gran variación entre los mismos y con diferentes métodos. Trece de las 15 MH tuvieron niveles altos de TT por LC MS/MS. De las MH con TT aumentada de acuerdo a la determinación por LC MS/MS entre el 12 y el 85 % de las mismas por los distintos métodos fueron normales, indicando que en la mayoría de los métodos habitualmente utilizados en nuestro medio subvaloran la hipernadrogenemia en estas pacientes. Estas diferencias se hacen más notorias a niveles más bajos de TT (Se obtuvieron valores normales en el 71 % de los casos con valores de TT entre 0.47 y 0.74 ng/ml y en el 38 % de los casos, con niveles de TT mayor a 0.98 ng/ml). En 9 muestras se determinó la TT empleando una curva en el rango de 0.21 a 6.44 ng/ml preparada con de una mezcla de 78 sueros cuyos valores fueron obtenidos por LC MS/MS. No se obtuvo una modificación significativa de los valores indicando que la diferencia entre los distintos métodos no es debida a las diferentes curvas de calibración de los kit comerciales. En conclusión ninguno de los métodos mayormente empleados en nuestro medio son aceptables para la evaluación de niveles menores a 1.5 ng/ml.(AU)

Pharmacokinetics of metaflumizone and amitraz in the plasma and hair of dogs following topical application.

Controlled laboratory studies have shown that a metaflumizone plus amitraz combination (ProMeris/ProMeris Duo for Dogs, Fort Dodge Animal Health, Overland Park, KS) applied topically is effective for the treatment and control of fleas and ticks on dogs. Two studies were conducted to determine the distribution of both metaflumizone and amitraz in the plasma and hair of dogs following treatment at the minimum recommended dose of approximately 20mg/kg of each active ingredient. Six purpose-bred, adult Beagle dogs were used in each study. Plasma or hair samples were collected from each dog just prior to dosing and periodically through 56 days after treatment. Samples were analyzed by HPLC methods validated for the simultaneous determination of metaflumizone and amitraz. Amitraz was detectable (>3.2ng/ml) but not quantifiable (<50ng/ml) in only two plasma samples, collected 1 and 2 days post-treatment from different dogs. Metaflumizone concentrations in plasma were generally detectable (>1.0ng/ml) but not quantifiable (<50ng/ml). Measurable levels were found in one dog 7 days post-treatment, increasing to a maximum of four dogs at 42 days after dosing, with a metaflumizone range of 59-138ng/ml. Analysis of hair samples indicated that both metaflumizone and amitraz were widely distributed at basically similar levels in the hair within 1-day after administration, reaching maximum concentrations between 2 and 7 days post-treatment. Low but quantifiable levels of both compounds were still present on hair at the end of the 56-day study. These studies indicate that the ectoparasitic activity is due to exposure of the parasites to metaflumizone and amitraz on the surface of the host (hair and/or skin), not to exposure via the circulatory system of the host.

Pharmacokinetics of metaflumizone in the plasma and hair of cats following topical application.

Controlled laboratory studies have shown that a novel spot-on formulation containing 20% (w/v) metaflumizone (ProMeris for Cats, Fort Dodge Animal Health, Overland Park, KS) is effective for the treatment and control of fleas on cats. Two studies were conducted to determine the distribution of metaflumizone in the plasma and hair of cats following treatment at the minimum recommended dose of 40mg/kg. Six purpose-bred cats, three males and three females, were used in each study. Plasma or hair samples were collected from each cat just prior to dosing and periodically through 56 days after treatment. Samples were analyzed by HPLC methods validated for the determination of metaflumizone. Metaflumizone concentrations in plasma were below the method limit of quantification (<50ng/ml) in all samples but one, and were frequently not detectable (<1.1ng/ml). Plasma collected 3 days post-treatment from one cat had a metaflumizone concentration of 57.8ng/ml. The frequency of measurable levels of metaflumizone in the plasma was too low to allow the calculation of pharmacokinetic parameters. Analysis of hair samples indicated that metaflumizone was widely distributed in the hair coat of the cat within 1 day after administration, reaching maximum concentrations within 1 or 2 days post-treatment. Low but quantifiable levels were still present at the end of the 56-day study. Data from the present studies indicate that the ectoparasitic activity is due to exposure of the parasites to metaflumizone on the surface of the host (skin and hair), not to exposure via the circulatory system of the host.

Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation.

Platelet concentrates (PCs) constitute new biological mediators used in osseous reconstructive surgery. In this study, we assessed (i) the effects of various concentrations of calcium and thrombin on the kinetics of platelet-derived growth factor (PDGF-BB), transforming growth factor-beta1(TGF-beta 1), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) release by PCs and (ii) the contribution of PC supernatants to endothelial cell proliferation. Our results indicate that high concentrations of calcium (Ca) and thrombin (Thr) trigger an immediate and significant increase in bFGF, TGF-beta 1 and PDGF-BB concentrations. Thereafter, PDGF-BB, VEGF and TGF-beta 1 levels remained generally constant over a 6-day period while a decrease in bFGF concentrations was noted after 24h. Lower Ca and Thr concentrations tended to reduce and delay growth factors release from PCs. Endothelial cell proliferation was greatly enhanced with PC supernatants (mean: 20-fold increase). This was especially evident when endothelial cells were treated with supernatants harvested early after PC treatment with high concentrations of Ca and Thr or later after PC treatment with low Ca and Thr concentrations. Additional research aiming to measure the effects of Ca and Thr on bone formation in vivo is needed.

Two glycogen synthase activities associated with proteoglycogen in retina.

Glycogen synthase of bovine retina was found associated with the acid-insoluble and acid-soluble proteoglycogen fractions. The synthase associated with the acid-insoluble proteoglycogen precursor showed an 8-fold lower Km for UDP-glucose than the synthase associated with the acid-soluble fraction, and was inhibited by detergent. A short digestion with pronase resulted in conversion of the acid insoluble fraction into acid-soluble. The results lead us to postulate that the acid-insolubility of the proteoglycogen fraction and the association with retina membrane proposed before, is caused by glycogen synthase strongly associated to its polysaccharide moiety. The enlargement of the polysaccharide moiety during proteoglycogen biosynthesis, from glycogenin linked to a few 11 to 12 glucose units to the acid-insoluble proteoglycogen precursor (Mr 470,000) would be carried out, together with the branching enzyme, by the glycogen synthase showing a low Km for UDP-glucose. The glycogen synthase with the highest Km for UDP-glucose would participate in conversion of the precursor into mature acid-soluble proteoglycogen.

Some pharmacokinetic parameters of eprinomectin in goats following pour-on administration.

Some pharmacokinetic parameters of eprinomectin were determined in goats following topical application at a dose rate of 0.5 mg/kg. The plasma concentration versus time data for the drug were analysed using a one-compartment model. The maximum plasma concentration of 5.60+/-1.01 ng/ml occurred 2.55 days after administration. The area under the concentration-time curve (AUC) was 72.31+/-1.15 ng day/ml and the mean residence time (MRT) was 9.42+/-0.43 days. Thus, the systemic availability of eprinomectin to goats was significantly lower than that for cows. The low concentration of eprinomectin in the plasma of goats suggests that the pour-on dose of 0.5 mg/kg would be less effective in this species than in cows. Further relevant information about the optimal dosage and residues in the milk of dairy goats is needed before eprinomectin should be used in this species.

[Antiseptic properties of essential oil of Lippia sidoides Cham. Application to the cutaneous microflora]. / Les propriétés antiseptiques de l'huile essentielle de Lippia sidoides Cham. Application à la microflore cutanée.

Two samples of essential oils of Lippia sidoides Cham. have been tested for their antibacterial and antifungal properties against some microorganisms living on the skin of feet and armpits. The essential oils and also their main components, thymol and carvacrol, show strong antagonistic activities. Corynebacterium xerosis developing axillary odour is specially inhibited. But on the other hand no specific activities have been observed upon the feet microflora.

A glycogen precursor associated with membrane in retina.

The incorporation of [14C]glucose from UDP-[14C]glucose into proteoglycogen fractions of a retinal microsomal preparation was studied. From the rate of labelling of acid-insoluble and -soluble proteoglycogen at different sugar-donor concentrations, and from the conversion of the labelled acid-insoluble into an acid-soluble form measured by a 'chase' with unlabelled UDP-glucose, it was concluded that acid-insoluble 42 kDa protein (p42)-bound glycogen of weight-average Mr 4.7 x 10(5) and acid-soluble p42-bound glycogen of weight-average Mr 7.0 x 10(5) [Miozzo, Lacoste & Curtino (1989) Biochem. J. 260, 287-289] are related as precursor and product respectively. About one-third of the acid-insoluble proteoglycogen was excluded from a Sephacryl S-500 column and was associated with large membrane vesicles. Proteoglycogen was not dissociated from the membranes by treatment with saline solutions or with SDS at a low detergent-to-protein ratio. It was dissociated by treatment with detergents under conditions which were shown to solubilize integral membrane sialoglycoconjugates of retina. These results lead us to postulate that the biogenesis of retina glycogen starts on membrane-associated p42 to form acid-insoluble proteoglycogen, which is then dissociated from membranes and converted into acid-soluble proteoglycogen by the 'growth' of its polysaccharide moiety.

Characterization of the proteoglycogen fraction non-extractable from retina by trichloroacetic acid.

The trichloroacetic acid-insoluble 1,4-alpha-glucan fraction from bovine retina was purified and characterized. It is a proteoglycogen fraction containing a 42 kDa protein moiety similar in size to the protein moiety of the trichloroacetic acid-soluble proteoglycogen fraction. The apparent weight-average Mr of acid-insoluble and acid-soluble proteoglycogens are 4.7 x 10(5) and 7.0 x 10(5) respectively. The present results support suggestions from earlier studies indicating that acid-insoluble proteoglycogen is the precursor of the acid-soluble form.